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The ADP-ribosylation factor 6 (ARF6) GTPase is important in cytokinesis, and localizes 
to the midbody. However, the mechanism and regulation of ARF6’s recruitment to the 
midbody are largely unknown. Here, we investigated the functions of two binding partners 
of active ARF6, c-Jun NH2-terminal kinase (JNK)/stress-activated protein 
kinase-associated protein 1 (JSAP1) and JNK-associated leucine zipper protein (JLP), by 
gene knockout and rescue experiments in mouse embryonic fibroblasts. Depleting both 
JSAP1 and JLP impaired ARF6’s localization to the midbody and delayed cytokinesis. 
These defects were almost completely rescued by wild-type JSAP1 or JLP, but not by 
JSAP1 or JLP mutants that were unable to interact with active ARF6 or with the kinesin 
heavy chain (KHC) of kinesin-1. In transfected cells, a constitutively active form of ARF6 
associated with KHC only when coexpressed with wild-type JSAP1 or JLP, and not with a 
JSAP1 or JLP mutant. These findings suggest that JSAP1 and JLP, which might be 
paralogous to each other, are critical and functionally redundant in cytokinesis, and control 
ARF6 localization to the midbody by forming a tripartite complex of JSAP1/JLP, active 







Cytokinesis is the final stage of cell division, in which a single cell is physically separated 
into two daughter cells. The failure of cytokinesis can lead to aneuploidy, which is often 
associated with cancer. There is growing evidence that membrane trafficking plays an 
important role during cytokinesis in animal cells (Albertson et al. 2005; Montagnac et al. 
2008). Although several small GTPases, including ADP-ribosylation factor 6 (ARF6), are 
known to regulate membrane trafficking during cytokinesis (D'Souza-Schorey & Chavrier 
2006; Schweitzer et al. 2011; Schiel & Prekeris 2013), the mechanisms that control these 
GTPases spatiotemporally are not well understood. ARF6, like other small GTPases, 
cycles between an active GTP-bound and an inactive GDP-bound state. Recent studies 
have shown that ARF6 is crucial for proper cytokinesis, and that it localizes to the 
midbody, a narrow intercellular bridge connecting two daughter cells (Chesneau et al. 
2012; Makyio et al. 2012). 
C-Jun NH2-terminal kinase (JNK)/stress-activated protein kinase-associated protein 1 
(JSAP1, also known as JIP3 or Sunday Driver) was originally identified as a binding 
protein for JNK, and was suggested to function as a scaffold in mammalian JNK signaling 
pathways (Ito et al. 1999; Kelkar et al. 2000). Subsequent genetic studies supported 
JSAP1’s role as a scaffold protein (Kelkar et al. 2003; Ha et al. 2005). In addition, recent 
studies have indicated that JSAP1 plays key roles in several neuronal processes, including 
axon elongation and branching (Suzuki et al. 2010; Bilimoria et al. 2010; Sun et al. 2013). 
The JNK-associated leucine zipper protein (JLP, also known as JIP4 or SPAG9) is closely 
related in structure to JSAP1, and can organize JNK and p38 mitogen-activated protein 
kinase signaling pathways (Lee et al. 2002; Kelkar et al. 2005). This scaffold protein is 
reported to be important in myoblast differentiation (Takaesu et al. 2006; Kang et al. 2008). 
Jsap1 and Jlp might be paralogous to each other. To date, however, whether JSAP1 and 
JLP have overlapping functions remains largely unknown. 
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JSAP1 and JLP have also been identified as kinesin light chain (KLC)-binding 
proteins, and are thought to function as adaptor proteins that link cargos to kinesin-1 
(Verhey et al. 2001; Nguyen et al. 2005), which is a heterotetramer of two kinesin heavy 
chains (KHC) and two KLC subunits. KHC includes a globular ATP-binding motor 
domain. Recently, JSAP1 and JLP were identified as binding partners for active ARF6 
(Montagnac et al. 2009; Suzuki et al. 2010). Montagnac et al. reported that active ARF6 
binds to JSAP1/JLP and negatively regulates the association of JSAP1/JLP with kinesin-1. 
In this study, we investigated the functions of JSAP1 and JLP by gene knockout (KO) and 
rescue experiments in mouse embryonic fibroblasts (MEFs). Our findings suggest that 
JSAP1 and JLP play critical, functionally redundant roles in cytokinesis by controlling 
ARF6’s localization to the midbody as part of a tripartite complex of JSAP1/JLP, active 






Phenotypic analysis of Jsap1 KO, Jlp KO, and Jsap1:Jlp double-KO (dKO) MEFs 
To examine the roles of JSAP1 and JLP in proliferating cells, we used wild-type and 
mutant mouse MEFs carrying loxP-flanked (floxed) Jsap1 and/or Jlp alleles, which allow 
a target gene to be disrupted by an adenovirus vector expressing Cre recombinase 
(AxCANCre). The disruption of Jsap1 and Jlp by AxCANCre was confirmed by 
immunoblotting at 24 h post-infection (hpi). JSAP1 and JLP were not detected in 
AxCANCre-infected Jsap1f/f or Jlpf/f MEFs, respectively (Fig. 1A, lanes 2 and 3), and 
neither protein was detected in AxCANCre-infected Jsap1f/f:Jlpf/f MEFs (lane 4). 
We first investigated whether JSAP1 and/or JLP are required for MEF proliferation. 
Equal numbers of wild-type or each mutant MEF were plated at low density, and the 
number of adherent MEFs was measured by 4’,6-diamidino-2-phenylindole (DAPI) 
staining at 24, 48, and 72 hpi (Fig. 1B and C). While Cre-induced Jsap1 and Jlp 
single-KO MEFs grew normally and the number of adherent cells was similar to that in 
wild-type MEFs at each time point examined, the number of adherent Jsap1:Jlp dKO 
MEFs was markedly reduced at 48 and 72 hpi, but not at 24 hpi (Fig. 1B and C). We next 
conducted rescue experiments using wild-type and altered forms of JSAP1, including a 
deletion mutant lacking the KHC-binding domain (KBD) (Sun et al. 2011) and a mutant 
that could not interact with GTP-bound active ARF6 due to substitutions in the leucine 
zipper domain (Montagnac et al. 2009; Suzuki et al. 2010, see also Fig. 3 and Fig. S5 in 
Supporting Information). Lentiviral vectors were used to express these wild-type and 
mutant JSAP1 forms as hemagglutinin (HA)-tagged proteins (designated HA-JSAP1-WT, 
-LZ, and -ΔKBD) in the Jsap1:Jlp dKO MEFs. The lentiviral vector-mediated expression 
of the HA-JSAP1 proteins in dKO MEFs was comparable to that of endogenous JSAP1 in 
wild-type MEFs (Fig. 1D). Although HA-JSAP1-WT almost completely reversed the 
reduced numbers of dKO MEF cells, neither the HA-JSAP1-LZ nor the ΔKBD mutant 
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was able to rescue the defect (Fig. 1E). Similar results were obtained with lentiviruses 
expressing HA-JLP-WT, -LZ, or -ΔKBD (Fig. S1 in Supporting Information). Taken 
together, these results suggest that JSAP1 and JLP are functionally redundant and play an 
important role in cell proliferation through interactions with kinesin-1 and ARF6. 
 
Delayed cytokinesis in Jsap1:Jlp dKO MEFs 
While analyzing the MEFs by DAPI staining, we noticed that the proportion of binucleate 
cells appeared to be higher in the Jsap1:Jlp dKO MEFs than in the wild-type MEFs. We 
found that the frequency of binucleate cells at 36 hpi was 3 times higher in the dKO MEFs 
than in wild-type MEFs (Fig. 2A and B). This percentage of binucleate cells in the dKO 
MEFs may actually be underestimated, because many of the dKO MEFs had detached 
from the plates during culture, and the proportion of adherent dKO MEFs at 36 hpi was 
around 30% of that in wild-type MEFs (T. Sato and K. Yoshioka, unpublished data). We 
conducted rescue experiments with lentiviruses expressing HA-JSAP1-WT, -LZ, or 
-ΔKBD, and HA-JLP-WT, -LZ, or -ΔKBD. As shown in Fig. 2B (and Fig. S2 in 
Supporting Information), HA-JSAP1/JLP-WT, but not HA-JSAP1/JLP-LZ or -ΔKBD, 
reversed the increased frequency of binucleate cells. 
 We next investigated whether ablating JSAP1 and JLP in MEFs would lead to 
defective cytokinesis. Uninfected wild-type MEFs and AxCANCre-infected wild-type and 
Jsap1f/f:Jlpf/f MEFs were cultured in the presence of RO-3306, a selective 
cyclin-dependent kinase 1 (CDK1) inhibitor (Vassilev et al. 2006), to arrest the cell cycle 
at the G2/M phase. The inhibitor was released at 24 hpi, and the arrested MEFs were 
allowed to enter mitosis with a large population of cells at the G2/M phase (Fig. S3 in 
Supporting Information). Cells in cytokinesis were identified by the presence of the 
midbody (Fig. 2C). We found comparable proportions of dKO MEFs and 
AxCANCre-infected or -uninfected wild-type MEFs in cytokinesis 2 h after releasing the 
RO-3306 block (Fig. 2D, left). Six hours after release, the percentage of wild-type cells 
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undergoing cytokinesis had severely decreased, whereas many dKO MEFs were still in 
cytokinesis (Fig. 2D, right). The lentivirus-mediated expression of HA-JSAP1/JLP-WT, 
but not of HA-JSAP1/JLP-LZ or -ΔKBD, reversed the increased proportion of cytokinetic 
cells in the dKO MEFs (Fig. 2E and Fig. S4 in Supporting Information). Collectively, 
these results suggest that JSAP1 and JLP regulate cytokinesis through their interactions 
with kinesin-1 and ARF6, and that the depletion of JSAP1 and JLP delays cytokinesis. 
 
Tripartite complex formation of JSAP1/JLP, ARF6, and kinesin-1 KHC 
JSAP1 and JLP are known to interact with active ARF6 and KHC. To determine whether 
JSAP1 forms a tripartite complex with ARF6 and kinesin-1 KHC, we transiently 
coexpressed HA-JSAP1 (WT, LZ, or ∆KBD) with a Flag-tagged, constitutively active 
ARF6 mutant (ARF6-Q67L-Flag) and Myc-tagged KHC (Myc-KHC) in human 
embryonic kidney (HEK) 293T cells. The cell lysates were then immunoprecipitated with 
an anti-HA antibody (Ab) and analyzed by immunoblotting with an anti-Flag or -Myc Ab 
(Fig. 3A). The results showed that HA-JSAP1-WT interacted with both ARF6-Q67L-Flag 
and Myc-KHC, HA-JSAP1-LZ interacted with Myc-KHC but not ARF6-Q67L-Flag, and 
HA-JSAP1-∆KBD interacted with ARF6-Q67L-Flag but not Myc-KHC. Similar results 
were obtained with HA-JLP-WT, -LZ, and -∆KBD (Fig. S5A in Supporting Information). 
We further assessed interactions between ARF6 and KHC in the presence or absence of 
JSAP1 by co-immunoprecipitation and immunoblotting assays in HEK 293T cells. 
Although ARF6-Q67L-Flag did not interact with Myc-KHC in the absence of 
HA-JSAP1-WT (Fig. 3B, lanes 3 and 7), ARF6-Q67L-Flag and Myc-KHC were detected 
in precipitates with anti-Myc and -Flag Abs, respectively, in the presence of 
HA-JSAP1-WT (Fig. 3B, lanes 4 and 8). Similar results were obtained with HA-JLP-WT 
(Fig. S5B in Supporting Information). Taken together, these results indicate that 
JSAP1/JLP, ARF6, and KHC can form a tripartite complex. 
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Impaired localization of ARF6 to the midbody in Jsap1:Jlp dKO MEFs 
ARF6 is known to localize to the midbody during cytokinesis. To test our hypothesis that 
JSAP1 and JLP are required for targeting ARF6 to the midbody, we compared the 
localization of endogenous ARF6 in wild-type and dKO MEFs. AxCANCre-infected 
wild-type and Jsap1f/f:Jlpf/f MEFs were cultured in the presence of RO-3306. The MEFs 
were released from the RO-3306 block at 24 hpi, and were stained with an Ab against 
ARF6 2 h later (Fig. 4). A large proportion of the acetyl-α-tubulin-positive intercellular 
bridges in the wild-type MEFs were stained by the anti-ARF6 Ab. The percentage of 
intercellular bridges stained for ARF6 was sharply decreased in the dKO MEFs; this 
decrease was reversed by the lentivirus-mediated expression of HA-JSAP1/JLP-WT, but 
not of HA-JSAP1/JLP-LZ or -ΔKBD (Fig. 4B and Fig. S6 in Supporting Information). 
 We next investigated whether ARF6's localization to the midbody is dependent on its 
interaction with JSAP1/JLP. ARF6-Q67L-Flag or a variant that could not interact 
specifically with JSAP1/JLP due to the additional point mutations T53E, K58C, and N60T 
(Suzuki et al. 2010), designated ARF6-Q67L-TriM-Flag, was coexpressed with either 
HA-JSAP1-WT or HA-JLP-WT in HEK 293T cells. We confirmed that 
HA-JSAP1/JLP-WT interacted with ARF6-Q67L-Flag, but not with 
ARF6-Q67L-TriM-Flag (Fig. 5A). We next used lentiviruses to express ARF6-Q67L-Flag 
and ARF6-Q67L-TriM-Flag in wild-type MEFs, and analyzed the localization of these 
proteins by immunofluorescence. The vast majority of acetyl-α-tubulin-positive 
intercellular bridges in the cells expressing ARF6-Q67L-Flag were Flag-positive, but the 
frequency of ARF6 localization to the intercellular bridges was severely decreased in cells 
expressing ARF6-Q67L-TriM-Flag (Fig. 5B and C). 
 Collectively, these results suggest that active ARF6 localizes to the midbody through 






In the present study, we explored the roles of JSAP1 and JLP in dividing cells. We found 
that JSAP1 and JLP are functionally redundant, and that the depletion of both proteins 
causes cytokinesis to fail. We propose that JSAP1 and JLP regulate ARF6’s localization to 
the midbody by forming a tripartite complex of JSAP1/JLP, active ARF6, and kinesin-1 
KHC. This proposal is supported by the following lines of evidence: The Jsap1:Jlp dKO 
MEFs exhibited an increased percentage of binucleate cells and delayed cytokinesis, 
which were both almost completely rescued by the expression of wild-type JSAP1 or JLP 
(JSAP1/JLP-WT), whereas JSAP1 or JLP mutants that could not interact with active 
ARF6 (JSAP1/JLP-LZ) or KHC (JSAP1/JLP-∆KBD) failed to reverse the defects (Fig. 2 
and Figs. S2 and S4 in Supporting Information). In transfected cells, the association of a 
constitutively active ARF6 mutant (ARF6-Q67L) and KHC was observed only with the 
co-expression of JSAP1/JLP-WT, but not JSAP1/JLP-LZ or JSAP1/JLP-∆KBD (Fig. 3 
and Fig. S5 in Supporting Information). In addition, the localization of endogenous ARF6 
to the midbody was impaired in Jsap1:Jlp dKO MEFs, and this impairment was reversed 
by the expression of JSAP1/JLP-WT, but not of JSAP1/JLP-LZ or JSAP1/JLP-∆KBD (Fig. 
4 and Fig. S6 in Supporting Information). Finally, in wild-type MEFs, ARF6-Q67L 
localized to the midbody with high frequency, consistent with previous reports 
(Schweitzer & D'Souza-Schorey 2002; Makyio et al. 2012), but this midbody localization 
was severely impaired by introducing three additional point mutations that prevented 
ARF6-Q67L's interaction with JSAP1/JLP (Fig. 5). These data collectively suggest that 
JSAP1 and JLP function as adaptors that link active ARF6 and kinesin-1. 
 Our findings are inconsistent with a previous study by Montagnac et al. (2009), 
which reported that ARF6-Q67L’s binding to JSAP1/JLP interferes with the association of 
JSAP1/JLP and kinesin-1 KHC. This apparent discrepancy may be explained by the 
different experimental systems used, and by differences in interpretation of the results. We 
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used a co-immunoprecipitation system in which ARF6-Q67L and KHC were transiently 
coexpressed with JSAP1/JLP-WT, -LZ, or -∆KBD in mammalian cells, and then 
ARF6-Q67L, KHC, and JSAP1/JLP were precipitated and their interactions evaluated by 
immunoblotting (Fig. 3 and Fig. S5 in Supporting Information). Montagnac et al. used a 
glutathione S-transferase (GST) pull-down system, in which KHC was pulled down from 
mammalian cells with a GST fusion protein containing the JLP leucine zipper domain, 
which is responsible for interactions with KLC and active ARF6, in the presence of 
ARF6-Q67L. This system pulls KHC down through its interaction with KLC. Montagnac 
et al. reported that ARF6-Q67L and KLC bind competitively to JSAP1/JLP; they showed 
that the amount of KHC pulled down decreased as the ARF6-Q67L concentration 
increased. These results, however, do not necessarily support the proposal that 
ARF6-Q67L binding to JSAP1/JLP negatively controls the association of JSAP1/JLP with 
kinesin-1 KHC. 
To date, no interaction has been shown between JSAP1/JLP and guanine nucleotide 
exchange factors (GEFs) for ARF6, which catalyze the transition from the inactive, 
GDP-bound ARF6 to an active, GTP-bound ARF6. Thus, ARF6 is probably activated 
independently from JSAP1/JLP, and later forms part of the tripartite complex. It was 
recently reported that ARF6 is transiently associated with the ingressing cleavage furrow 
when activated by its GEF EFA6, and is subsequently targeted to the Flemming body, the 
central region of the midbody, during late cytokinesis (Makyio et al. 2012; Ueda et al. 
2013). JSAP1/JLP might load activated ARF6 at the cleavage furrow and transport it to 
the midbody in collaboration with kinesin-1. Further study is needed to investigate the 







All experimental procedures involving mice were approved by the Institutional Animal 
Care and Use Committee of Kanazawa University. Jsap1f/f mice were generated previously 
(Iwanaga et al. 2007). The generation of mice carrying floxed alleles of Jlp will be 
described elsewhere in detail. Briefly, two loxP sites were inserted into the intronic regions 
flanking exon 5 of the Jlp gene. Heterozygous mice (Jlpf/+) were crossed with Jsap1f/+ mice 
to generate Jsap1f/+:Jlpf/+ mice. These mutant mice were backcrossed to C57BL/6 for more 
than ten generations, and the resulting mice were used in this study. C57BL/6 mice were 
obtained from Japan SLC (Hamamatsu, Japan). 
 
Cell cultures 
MEFs were prepared from 14.5-day-old embryos from wild-type C57BL/6, Jsap1f/f, Jlpf/f, 
and Jsap1f/f:Jlpf/f mice. After removing the heads and internal organs, the embryos were 
minced, trypsinized, and re-suspended in Dulbecco’s modified Eagle’s medium 
(Sigma-Aldrich, St. Louis, MO, USA) containing 10% fetal bovine serum. MEFs were 
used until passage 5. HEK 293T cells were cultured as described previously 
(Bayarsaikhan et al. 2007). In some experiments, RO-3306 (10 µM, Santa Cruz 
Biotechnology, Santa Cruz, CA, USA) was dissolved in dimethyl sulfoxide (DMSO) and 
added to the culture medium (see figure legends). 
 
Plasmids 
The mammalian expression plasmid pCL20c-CMV-HA-JSAP1-WT was described 
previously (Sato et al. 2008). The coding sequence for full-length JSAP1 with four 
leucine-to-alanine substitutions (at residues 431, 438, 445, and 452), a deletion mutant of 
JSAP1 KBD (residues 51-81), full-length mouse JLP (Iwanaga et al. 2008), full-length 
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JLP with four leucine-to-alanine substitutions (at residues 406, 413, 420, and 427), or a 
deletion mutant of JLP KBD (residues 45-75), was inserted into pCL20c-CMV-HA to 
generate pCL20c-CMV-HA-JSAP1-LZ, -JSAP1-∆KBD, -JLP-WT, -JLP-LZ, and 
-JLP-∆KBD, respectively. To generate pCL20c-ARF6-Q67L-Flag and 
-ARF6-Q67L-TriM-Flag, we subcloned the coding regions of full-length mouse ARF6 
(NM_007481) with either one substitution (Q67L) or four substitutions (T53E, K58C, 
N60T, and Q67L) and a Flag tag sequence at the 3’ end into pCL20c-CMV. These coding 
sequences were also inserted into pcDNA3 (Life Technologies, Carlsbad, CA, USA) to 
generate the expression plasmids pcDNA3-ARF6-Q67L-Flag and 
-ARF6-Q67L-TriM-Flag. The coding region for full-length mouse KHC (NM_008449) 
with a Myc tag sequence at the 5’ end was inserted into pcDNA3. The resultant plasmid 
was designated pcDNA3-Myc-KHC. Substitutions and deletions in cDNAs were 
introduced by overlapping polymerase chain reaction (PCR), as described previously (Ito 
et al. 1999). All PCR products were verified by sequencing. 
 
Viral infection and DAPI-staining analysis 
To generate Jsap1 KO, Jlp KO, or Jsap1:Jlp dKO MEFs, the corresponding MEFs were 
infected with AxCANCre (a gift from I. Saito). For DAPI staining, MEFs were plated in 
12-well plates at 5 x 103 cells per well and were infected with AxCANCre. The medium 
containing the virus was removed at 2.5 hpi, and the MEFs were washed twice with fresh 
medium and then cultured in fresh medium. At 24, 48, and 72 hpi, the MEFs were washed 
once with phosphate-buffered saline, fixed with 4% paraformaldehyde, and stained with 
DAPI (Sigma-Aldrich). DAPI-positive cells in five randomly chosen fields (1.4 mm2 per 
field) were counted for each experiment. Images were captured with a fluorescence 
microscope (Olympus IX71, Olympus, Tokyo, Japan). The pCL20c series of lentiviral 
vectors was produced as described previously (Sato et al. 2008). MEFs were infected with 





MEFs were plated in 9-cm dishes at 1 x 105 cells per dish, and were cultured in the 
presence of either DMSO (vehicle) or RO-3306. MEFs were harvested after 22 h, and 
were fixed with 70% ethanol, treated with RNase A (Sigma-Aldrich), stained with 
propidium iodide (Sigma-Aldrich), and analyzed by a flow cytometer (FACSCanto II, BD 
Biosciences, San Jose, CA, USA). 
 
Transfection, immunoprecipitation, and immunoblotting 
HEK 293T cells were plated in 35-mm dishes at 2 x 105 cells per dish, and were 
co-transfected with expression plasmids using polyethylenimine, essentially as described 
previously (Tanahashi et al. 2010). Twenty-four hours after transfection, the cells were 
lysed in lysis buffer (25 mM Tris-HCl pH 7.5, 1 mM EDTA, 5 mM MgCl2, 10 mM KCl, 
and 1% TritonX-100) containing Protease Inhibitor Cocktail (Sigma-Aldrich), and were 
analyzed by immunoblotting as described previously (Sato et al. 2004) using the following 
Abs: rabbit polyclonal anti-JSAP1 (0.33 µg/ml; Miura et al. 2006), rabbit polyclonal 
anti-JLP (2 µg/ml; Iwanaga et al. 2008), rat polyclonal anti-HA (1:5000; Roche, Basel, 
Switzerland), mouse monoclonal horseradish peroxidase (HRP)-conjugated anti-Flag M2 
(1:1000; Sigma-Aldrich), mouse monoclonal anti-Myc (1:3000; Cell Signaling 
Technology, Beverly, MA, USA), and rabbit polyclonal anti-actin (1:1000; Sigma-Aldrich). 
The following secondary HRP-conjugated IgG Abs were used: sheep anti-mouse and 
donkey anti-rabbit (1:5000, both from GE Healthcare, Buckinghamshire, UK), and goat 
anti-rat (1:5000, Santa Cruz Biotechnology). Protein bands were visualized using the 
Immobilon Western Chemiluminescence system (Millipore, Bedford, MA, USA). To 
analyze protein-protein interactions, cell lysates (prepared as described above) were 
immunoprecipitated with rat polyclonal anti-HA (1:500; Roche), mouse monoclonal 
 13 
anti-Flag M2 (1:1000; Sigma-Aldrich), or mouse monoclonal anti-Myc (1:1000; Cell 
Signaling Technology) Abs bound to protein G-Sepharose (GE Healthcare) beads, and 
were analyzed by immunoblotting. 
 
Immunocytochemistry 
For immunocytochemical analysis, MEFs were plated onto glass cover slips (Thermo 
Fisher Scientific, Waltham, MA, USA) in 12-well plates at 5 x 103 cells per well. The 
MEFs were left uninfected or were infected with AxCANCre and/or lentiviruses, as 
indicated in the figures. To quantify binucleate cells, MEFs were fixed at 36 h after 
infection with AxCANCre. To analyze the number of cytokinetic cells, MEFs were treated 
with the CDK1 inhibitor RO-3306, were released from the inhibitor, and were fixed at the 
time points indicated in the figure legends. The fixed MEFs were stained with DAPI and 
mouse monoclonal anti-α-tubulin Ab (1:2000; Sigma-Aldrich). To analyze ARF6’s 
localization during cytokinesis, MEFs were cultured in the presence of RO-3306, fixed 2 h 
after the RO-3306 blockade was released, and immunostained with rabbit monoclonal 
anti-acetyl-α-tubulin (1:1500; Cell Signaling) and either mouse monoclonal anti-ARF6 
(1:100; Santa Cruz Biotechnology) or mouse monoclonal anti-Flag M2 (1:2000; 
Sigma-Aldrich) Abs. The secondary Abs used were goat Alexa fluor 488-conjugated 
anti-mouse IgG and goat Alexa fluor 568-conjugated anti-rabbit IgG Abs (both diluted 
1:1000; Life Technologies). Immunocytochemistry was performed by standard protocols 
as described previously (Sato et al. 2011). Images were captured with a confocal laser 
scanning microscope (LSM510; Zeiss, Oberkochem, Germany). 
 
Statistical analysis 
Significance was determined using a two-tailed unpaired Student’s t-test. P < 0.05 was 
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Figure 1. Phenotypic analysis of Jsap1 KO, Jlp KO, and Jsap1:Jlp dKO MEFs. (A) 
Cre-induced deletion of Jsap1 and Jlp in MEFs. Wild-type (WT), Jsap1f/f, Jlpf/f, and 
Jsap1f/f:Jlpf/f MEFs infected with AxCANCre were analyzed at 24 hpi by immunoblotting 
with anti-JSAP1 and anti-JLP Abs. Actin was used as a loading control. (B) MEFs were 
infected with AxCANCre, and the number of DAPI-positive adherent MEFs was counted 
at the indicated times. (C) Quantification of the results in B. (D) Jsap1f/f:Jlpf/f MEFs 
infected with lentiviruses expressing HA-JSAP1-WT, -LZ, or -∆KBD were further 
infected with AxCANCre and were analyzed 24 h later by immunoblotting, as in A. WT 
MEFs were used as a control. (E) The number of DAPI-positive adherent MEFs 
expressing the indicated HA-JSAP1s was counted 48 h after infection with AxCANCre; 
results were quantified as in C. Values are the mean + SEM from three independent 
experiments; n.s., not significant; **P < 0.01; scale bar, 200 µm. 
 
Figure 2. Delayed cytokinesis in Jsap1:Jlp dKO MEFs. (A,B) WT and Jsap1f/f:Jlpf/f 
MEFs expressing the indicated HA-JSAP1s were infected with AxCANCre. At 36 hpi, the 
cells were stained with DAPI and α-tubulin, and the number of binucleate cells (arrows) in 
WT and dKO MEFs expressing the indicated HA-JSAP1s was counted. (C) Cytokinetic 
cells (arrowheads) in MEFs. WT and Jsap1f/f:Jlpf/f MEFs infected with AxCANCre were 
treated with RO-3306. The MEFs were released from RO-3306 at 24 hpi and were stained 
with DAPI (blue) and anti-α-tubulin Ab (green) at the indicated time points after the 
release. Inset shows a magnified view of the dashed boxed area. (D) Quantification of the 
results in C. (E) Delayed cytokinesis in dKO MEFs was rescued by the expression of 
HA-JSAP1-WT, but not of HA-JSAP1-LZ or -∆KBD. Cytokinetic cells in dKO MEFs 
expressing the indicated HA-JSAP1s were counted 6 h after the cells were released from 
RO-3306. For each experiment, 200-1000 cells and 200-400 cells were counted for the 
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analysis of binucleate and cytokinetic cells, respectively. Values are the mean + SEM from 
three independent experiments; n.s., not significant; **P < 0.01; ***P < 0.001; scale bars, 
100 µm. 
 
Figure 3. JSAP1 forms a tripartite complex with active ARF6 and KHC. HEK 293T cells 
were transiently transfected with various combinations of expression plasmids for 
HA-JSAP1-WT, (-LZ or -∆KBD), ARF6-Q67L-Flag, and Myc-KHC as indicated. The 
cells were lysed, immunoprecipitated (IP) with anti-HA Ab (A), anti-Myc, or -Flag Ab (B), 
and analyzed by immunoblotting (IB) using anti-Flag, -Myc, or -HA Ab as indicated. The 
expression of HA-JSAP1s, ARF6-Q67L-Flag, or Myc-KHC in the total cell lysates is also 
shown (input). 
 
Figure 4. The localization of ARF6 to the midbody is impaired in Jsap1:Jlp dKO MEFs. 
(A) WT and Jsap1f/f:Jlpf/f MEFs infected with AxCANCre were treated with RO-3306. 
The MEFs were released from RO-3306 at 24 hpi and immunostained with anti-ARF6 
(green) and anti-acetyl (ac)-α-tubulin (red) Abs 2 h later. Nuclei were stained with DAPI 
(blue). Arrowheads indicate endogenous ARF6 localized to intercellular bridges. (B) The 
number of ARF6-positive intercellular bridges in the MEFs in A and in dKO MEFs 
lentivirally expressing the indicated HA-JSAP1s were counted as in A. Twenty 
intercellular bridges were analyzed per experiment. Values are the mean + SEM from three 
independent experiments; n.s., not significant; ***P < 0.001; scale bars, 20 µm. 
 
Figure 5. The localization of active ARF6 to the midbody requires its interaction with 
JSAP1/JLP. (A) Interaction of HA-JSAP1/JLP-WT with ARF6-Q67L-Flag or 
ARF6-Q67L-TriM-Flag. HEK 293T cells were transiently transfected with various 
combinations of expression plasmids, as indicated. The cells were lysed, 
immunoprecipitated (IP) with anti-Flag Ab, and analyzed by immunoblotting (IB) using 
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anti-Flag or anti-HA Abs as indicated. The HA-JSAP1/JLP-WT, ARF6-Q67L-Flag, or 
ARF6-Q67L-TriM-Flag expressed in the total cell lysates is also shown (input). (B) 
Localization of ARF6-Q67L-Flag and ARF6-Q67L-TriM-Flag in MEFs. 
AxCANCre-infected WT MEFs expressing ARF6-Q67L-Flag or ARF6-Q67L-TriM-Flag 
were treated with RO-3306, were released from RO-3306 at 24 hpi, and were 
immunostained with anti-Flag (green) and anti-ac-α-tubulin (red) Abs 2 h later. Nuclei 
were stained with DAPI (blue). The right-hand panels in “ARF6-Q67L-Flag” and 
“ARF6-Q67L-TriM-Flag” show magnified views of the boxed region indicated in the left 
panels. Arrowheads indicate ARF6-Q67L-Flag that is localized to the intercellular bridge. 
(C) Quantification of the results in B. Twenty intercellular bridges were analyzed per 
experiment. Values are the mean + SEM from three independent experiments; ***P < 






Figure S1. The decreased number of adherent Jsap1:Jlp dKO MEFs was rescued by 
JLP-WT, but not by JLP-LZ or JLP-∆KBD. (A) Lentiviral-mediated expression of 
HA-JLP-WT, -LZ, and -∆KBD. Jsap1f/f:Jlpf/f MEFs infected with lentiviruses expressing 
the indicated HA-JLPs were further infected with AxCANCre, and were analyzed by 
immunoblotting at 24 hpi (see Fig. 1A). WT MEFs were used as a control. (B) 
Quantification of DAPI-positive MEFs expressing various HA-JLPs. DAPI-positive 
adherent MEFs expressing the indicated HA-JLPs were counted 48 h after infection with 
AxCANCre, and the results were quantified as in Fig. 1E. Values are the mean + SEM 
from three independent experiments; n.s., not significant; **P < 0.01. 
 
Figure S2. The increased proportion of binucleate cells in Jsap1:Jlp dKO MEFs was 
rescued by JLP-WT, but not by JLP-LZ or JLP-∆KBD. Jsap1f/f:Jlpf/f MEFs infected with 
lentiviruses expressing the indicated HA-JLPs were further infected with AxCANCre, 
were stained with DAPI and anti-α-tubulin Ab at 36 hpi, and the number of binucleate 
cells was counted for each type of MEF and quantified as in Fig. 2B. In each experiment, 
200-1000 cells were counted. Values are the mean + SEM from three independent 
experiments; n.s., not significant; **P < 0.01. 
 
Figure S3. The cell cycle profile of MEFs treated with RO-3306. WT MEFs were cultured 
in the presence of either DMSO or RO-3306 and were analyzed by flow cytometry. 
 
Figure S4. Delayed cytokinesis in Jsap1:Jlp dKO MEFs was rescued by JLP-WT, but not 
by JLP-LZ or JLP-∆KBD. Jsap1f/f:Jlpf/f MEFs infected with lentiviruses expressing the 
indicated HA-JLPs were further infected with AxCANCre, and were cultured in the 
presence of RO-3306. Cytokinetic cells were counted 6 h after the MEFs were released 
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from RO-3306, and were quantified as in Fig. 2D. In each experiment, 200-400 cells were 
counted. Values are the mean + SEM from three independent experiments; n.s., not 
significant; *P < 0.05; ***P < 0.001. 
 
Figure S5. JLP forms a tripartite complex with active ARF6 and KHC. HEK 293T cells 
were transiently transfected with various combinations of expression plasmids for 
HA-JLP-WT, (-LZ or -∆KBD), ARF6-Q67L-Flag, and Myc-KHC as indicated. The cells 
were lysed, were immunoprecipitated (IP) with anti-HA, (A) anti-Myc, or anti-Flag Ab 
(B), and were analyzed by immunoblotting (IB) using anti-Flag, -Myc, or -HA Ab as 
indicated. The expression of HA-JLPs, ARF6-Q67L-Flag, or Myc-KHC in total cell 
lysates is shown (input). 
 
Figure S6. The impaired localization of ARF6 to the midbody in Jsap1:Jlp dKO MEFs 
was rescued by JLP-WT, but not by JLP-LZ or JLP-∆KBD. Jsap1f/f:Jlpf/f MEFs infected 
with lentiviruses expressing the indicated HA-JLPs were further infected with AxCANCre, 
cultured in the presence of RO-3306, and immunostained with anti-ARF6 and 
anti-acetyl-α-tubulin Abs 2 h after the release of RO-33. ARF6-positive intercellular 
bridges in the dKO MEFs were counted and quantified as in Fig. 4B. Twenty intercellular 
bridges were analyzed per experiment. Values are the mean + SEM from three 
independent experiments; n.s., not significant; ***P < 0.001. 
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